PinkDx, Inc., a Daly Metropolis, CA-based firm centered on positively impacting the well being of girls all through their life journey, raised $40m in Sequence A financing.
The spherical was co-led by Catalio Capital Administration, LP, and The Manufacturing Board. Different traders embody Mountain Group Companions, Byers Capital and Mayo Clinic.
The corporate will use the funds to check growth, focusing initially on gynecological cancers.
Led by Bonnie Anderson, cofounder, chairwoman and chief government officer, and CSO Giulia C. Kennedy, Ph.D., and chief monetary officer and chief enterprise officer Tim McMeekan, PinkDx is an early-stage firm centered on addressing the medical issues that ladies face by making use of scientific approaches to resolve them and offering solutions which have an instantaneous, optimistic impression on their lives. The corporate’s first indication will concentrate on overcoming diagnostic challenges for girls who current with normal signs that might sign a gynecological most cancers.
PinkDx additionally introduced that Alison Cowan, M.D., M.S.C.R., has joined the corporate as chief medical officer and can information the medical growth of PinkDx’s options. Previous to becoming a member of PinkDx, Dr. Cowan served as head of Medical Affairs for Mirvie and earlier than that as medical director for Hologic’s Diagnostics division. She has 14 years of medical expertise in each educational and group settings and maintains a medical apply as an OB/GYN hospitalist in Colorado. Dr. Cowan acquired her medical diploma and grasp’s in medical analysis from Emory College and accomplished her OB/GYN residency at Northwestern College.
FinSMEs
25/04/2024
